These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2701749)

  • 1. [Possibility of using TFX (thymus factor X) in the treatment of systemic lupus erythematosus].
    Lasisz B; Zdrojewicz Z; Dul W; Markiewicz A; Strychalski J
    Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):724-5. PubMed ID: 2701749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of the treatment of systemic lupus erythematosus with preparations of the methylxanthine group and T-activin].
    Biriukov AV; Stenina MA; Anan'eva LP; Skripnik AIu; Cheredeev AN
    Klin Med (Mosk); 1987 Jan; 65(1):107-11. PubMed ID: 3550275
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of treatment outcome in patients with rheumatoid arthritis treated with TFX- Polfa or gold salts after a one year follow up].
    Lewandowicz J
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1102-4. PubMed ID: 1305735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Antinuclear autoimmunization in Swan mice. Prevention and regression by treatment with thymosin].
    Monier JC; Deschaux P; Fontanges R
    Nouv Presse Med; 1975 Feb; 4(7):507. PubMed ID: 1079341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of the treatment of rheumatoid arthritis with TFX (thymus factor X)].
    Lasisz B; Zdrojewicz Z; Dul W; Strychalski J
    Wiad Lek; 1990 Sep 1-15; 43(17-18):870-3. PubMed ID: 2278144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of anticardiolipin antibody levels under immunoadsorption therapy.
    Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
    Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
    Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
    Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
    J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and patho-clinical observations of a patient with rectal carcinoma after long term administration of thymic extract (TFX).
    Turowski G; Urban A; Cybulski L; Turaszwili T; Zubel M
    Pol Med Sci Hist Bull (1973); 1976; 15(1):51-8. PubMed ID: 995756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines.
    Tamimoto Y; Horiuchi T; Tsukamoto H; Otsuka J; Mitoma H; Kimoto Y; Nakashima H; Muta K; Abe Y; Kiyohara C; Ueda A; Nagasawa K; Yoshizawa S; Shimoda T; Harada M
    Rheumatology (Oxford); 2008 Jun; 47(6):821-7. PubMed ID: 18397955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
    Tarr T; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2005 Dec; 146(49):2485-9. PubMed ID: 16398313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Associated autoimmune and immunodeficiency states in a patient with systemic lupus erythematosus complicated by suppurative infection. Clinical and immunological effectiveness of treatment with T-activin and methylxanthines].
    Stenina MA; Buriukov AV; Solov'ev SK; Sazhina EG; Skripnik AIu
    Ter Arkh; 1986; 58(3):105-9. PubMed ID: 3520917
    [No Abstract]   [Full Text] [Related]  

  • 17. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
    Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
    Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
    Schulman S; Langevitz P; Livneh A; Mortinowitz U; Seligsohn U; Varon D
    Thromb Haemost; 1996 Sep; 76(3):344-6. PubMed ID: 8883268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review.
    Khalidi NA; Rebello R; Robertson DD
    J Laryngol Otol; 2008 Dec; 122(12):1371-6. PubMed ID: 18282337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.